Targeted molecular therapy (modified RIST regimen) in relapsed high risk stage IV neuroblastoma: two cases report

Authors: Paolo Indolfi, Selim Corbacioglu, Silverio Perrotta, Francesca Rossi, Antonio Marte, et al.
Journal: Theory and Clinical Practice in Pediatrics
DOI: 10.25082/TCPP.2018.01.002
Pub. Date:
 Jan 2, 2018